ACS is committed to helping combat the global COVID-19 pandemic with initiatives and free resources. Learn More

Sadiq Shah

Barry Bunin

Dr. Shah recently retired as the Associate Vice President for Research and Sponsored Programs at the University of Texas Rio Grande Valley (UTRGV), and has served as the Vice Provost for Research at the University of Texas - Pan American (UTPA) with responsibilities for managing, directing and growing the research, scholarship and creative activities as well as technology transfer efforts on campus. He also served as the interim Vice president for Research at the University of Texas – Brownsville (UTB) and facilitated the transition of research enterprises at UTB and UTPA into a new university, UTRGV.

Prior to this Dr. Shah served as the Associate Vice President for Research and Economic Development at Western Kentucky University, served as the Chief Executive Officer and Chair of the Board of Directors for the WKU Research Foundation. Prior to that he served as the founding Director of the Western Illinois Entrepreneurship Center at Western Illinois University. He helped facilitate the start-up of 23 companies in West Central Illinois. After receiving his doctorate in chemistry from Washington University, St. Louis, in 1986, Dr. Shah joined Petrolite Corporation as a Senior Research Chemist with responsibilities for New Technology Development. In 1991 he joined Calgon Vestal Laboratories, A subsidiary of Merck Pharmaceuticals, in St. Louis as a Group Leader for Product & Technology Development. The ownership of the company evolved from Merck to Bristol-Myers Squibb and then STERIS Corporation. Dr. Shah’s responsibilities with the company evolved in management of the R&D efforts in Infection Control, Wound Management, Decontamination, Product and Process Development and the Engineering group with responsibilities for product delivery technologies at different stages of his tenure with the company.

Dr. Shah has been responsible for guiding the development of 20 new products from concept to launch and 7 technology platforms. Dr. Shah has 19 patents. Dr. Shah has edited three books, written book chapters, published 35 research articles and other articles related to technology transfer.